INTRODUCTION: Cell free DNA (cfDNA) is of considerable interest as a marker and pathogenesis factor in sepsis. Two processes are sources of cfDNA: cell death with the ingress of the contents of the cell nucleus into the bloodstream and the release of extracellular neutrophil traps (NETs). The marker of NETs formation is histone type 3.1. CfDNA and NETs in sepsis act in a dual role — they characterize the degree of cellular damage and the intensity of the inflammatory response, and at the same time they are etiological agents of these two processes. OBJECTIVE: This study aimed to analyze the level of nucleosomes containing histones of the H3.1 type (nucleosomes H3.1) in patients with septic shock, and the correlation of the nucleosome level with clinical and laboratory data of patients, especially the risk of developing significant clinical events. MATERIALS AND METHODS: The prospective single-center observational study included 52 patients with septic shock (Sepsis-3 criteria), admitted to the intensive care unit. RESULTS: The total number of patients was n = 52, with the severity score SOFA 10 ± 4. The median concentration of Nu.H3.1 was 4658 ± 3962 ng/ml, cfDNA — 3041 (876–7815) ng/ml. The most significant correlations of Nu.H3.1 were recorded with the lactate level (rxy = 0.4; p = 0.004) and the SOFA scale (rxy = 0.41; p = 0.002). For Nu.H3.1, a significant association with 28-day mortality and AKI was determined. CONCLUSIONS: The study showed that the marker of NETs formation — the level of Nu.H3.1 is an independent predictor of mortality and the development of AKI in septic shock, its threshold concentration was identified. It was associated with a risks of these significant clinical events. So this level can be considered as a laboratory benchmark in determining the indications for extracorporeal elimination of DNA-containing structures from the bloodstream. Objective. This study aimed to analyze the level of nucleosomes containing histones of the H3.1 type (nucleosomes H3.1) in patients with septic shock, and the correlation of the nucleosome level with clinical and laboratory data of patients, especially the risk of developing acute kidney injury (AKI) and 28-day mortality. Material and methods. The prospective single-center observational pilot study included 52 patients over 18 years old with septic shock (Sepsis-3 criteria), admitted to the intensive care unit of the State Healthcare Institution "City Clinical Hospital named after S.S. Yudin" between August 2023 and May 2024. Results. The total number of patients included in the study was n=52 (64% men, 36% women) aged 52.1 ± 17.3 years, with the severity scores SOFA 10±4 and Apache II - 22±7 points, respectively. The median concentration of Nu.H3.1 was 4658± 3962 ng/ml, cfDNA - 3041 (876-7815.0) ng/ml. The correlation between cfDNA and Nu.H3.1 had a noticeable direct relationship (r xy = 0.67, p = 0.0001). The most significant correlations of Nu.H3.1 were recorded with the lactate level (r xy = 0.4, p = 0.004) and the SOFA scale (r xy = 0.41, p = 0.002). For Nu.H3.1, a significant association with 28-day mortality (AUC 0.68, 95% CI (0.53-0.84) p = 0.037) and AKI (AUC 0.74, 95% CI (0.57-0.90) p = 0.014) was determined. The OR for the development of AKI at a concentration of Nu.H3.1> 2731 ng / ml was 6.0 (95% CI: 1.6-26.0, p < 0.018), sensitivity, specificity - 67% and 75%, respectively. For 28-day mortality at a concentration of Nu.H3.1 > 2731 ng / ml, the OR was 4.4 (95% CI: 1.2-15.6; p = 0.03), sensitivity, specificity - 67 and 79%, respectively. Conclusion. The study showed that the marker of NETs formation – the level of Nu.H3.1 is an independent predictor of mortality and the development of AKI in septic shock, its threshold concentration was identified. It was associated with a risks of these significant clinical events. So this level can be considered as a laboratory benchmark in determining the indications for extracorporeal elimination of DNA-containing structures from the bloodstream.